Bank of Montreal
PDSB icon

Bank of Montreal’s PDS Biotechnology PDSB Stock Holding History

Bank of Montreal’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-43,500
Closed -$249 – 4342
2022
Q2 		$249 Buy
+43,500
New +$207K ﹤0.01% 3121
2018
Q1 		– Sell
-50
Closed -$9K – 4288
2017
Q4 		$9K Buy
+50
New +$10.1K ﹤0.01% 3812
2016
Q2 		– Sell
-600
Closed -$110K – 4265
2016
Q1 		$110K Buy
+600
New +$107K ﹤0.01% 2763

Other funds holding PDSB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Bank of Montreal's PDSB Position: Q3 2022 in Review

Bank of Montreal sold out of PDS Biotechnology (PDSB) in Q3 2022, closing a stake of 43,500 shares — an estimated $249 sold.

Bank of Montreal first reported a position in PDSB in Q1 2016 and held it in 3 quarters. The position peaked at $110K in Q1 2016. 47 funds tracked by Wall St. Rank hold PDSB as of Q3 2022.

  • Bank of Montreal reported no remaining PDS Biotechnology position as of Q3 2022 after selling out during the quarter.
  • Bank of Montreal sold 43,500 PDS Biotechnology shares in Q3 2022, an estimated $249.
  • Bank of Montreal first reported a position in PDS Biotechnology in Q1 2016 and held it in 3 quarters.
  • Bank of Montreal's PDS Biotechnology position peaked at $110K in Q1 2016.
  • 47 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2022.

Based on Bank of Montreal's 13F filing for Q3 2022, filed 10 Nov 2022.